MBCL-11. TIME TO RADIOTHERAPY IMPACTS SURVIVAL IN PEDIATRIC AND ADOLESCENT NON-METASTATIC MEDULLOBLASTOMA TREATED BY UPFRONT RADIOTHERAPY – A REPORT FROM THE HIT 2000 TRIAL

PURPOSE: To evaluate prognostic factors and impact of participation in a randomized trial in non-metastatic medulloblastoma. METHODS AND PATIENTS: 382 patients with non-metastatic medulloblastoma aged 4–21 years with primary neurosurgical resections between 2001 and 2011 were enrolled into the HIT 2...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neuro Oncol
Main Authors: Dietzsch, Stefan, Placzek, Felix, Pietschmann, Klaus, von Bueren, André O, Matuschek, Christiane, Glück, Albrecht, Guckenberger, Matthias, Budach, Volker, Welzel, Jutta, Pöttgen, Christoph, Schmidberger, Heinz, Heinzelmann, Frank, Paulsen, Frank, Pazos, Montserrat, Schwarz, Rudolf, Hornung, Dagmar, Martini, Carmen, Grosu, Anca Ligia, Meyer, Frank Michael, Jablonska, Karolina, Dunst, Juergen, Kapp, Karin S, Dieckmann, Karin, Timmermann, Beate, Pietsch, Torsten, Warmuth-Metz, Monika, Kwiecien, Robert, Benesch, Martin, Gerber, Nicolas U, Pfister, Stefan M, Clifford, Steven C, von Hoff, Katja, Klagges, Sabine, Rutkowski, Stefan, Kortmann, Rolf-Dieter, Mynarek, Martin
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2020
Assuntos:
Medulloblastoma (Clinical)
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7715814/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noaa222.487
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados